You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Portal vein tumor thrombosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCC With Portal Vein Tumor Thrombosis on Basis of Risk Scoring

Completed
  • Hepatocellular Carcinoma
  • +2 more
    • Daegu, DalSeo-gu, Korea, Republic of
      Keimyung university Dongsan Medical Center
    Aug 16, 2023

    Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Lenvatinib, Transarterial Chemoembolization (TACE))

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Wuhan, Hubei, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 17, 2023

    HepatoCellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Sorafenib)

    Completed
    • HepatoCellular Carcinoma
    • Portal Vein Thrombosis
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Oct 8, 2021

    Predict Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma

    Completed
    • Neutrophil Extracellular Trap Formation
    • Portal Vein Tumor Thrombosis
    • test NETs markers
    • Qingdao, Shandong, China
      the Affiliated Hospital of Qingdao University
    Sep 2, 2021

    Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombosis, Stereotactic Body Radiotherapy Trial in Hangzhou

    Completed
    • Hepatocellular Carcinoma Non-resectable
    • +2 more
    • stereotactic body raiotherapy
    • Hangzhou, Zhejiang, China
      the second affiliated hospital of Zhejiang University
    Jul 11, 2021

    Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombus, Immune Checkpoint Inhibitors Trial in Nanning (Cadonilimab,

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • +2 more
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Sep 13, 2023

    Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Lenvatinib 1, Camrelizumab 1)

    Recruiting
    • Hepatocellular Carcinoma
    • Portal Vein Thrombosis
    • HAIC
    • +4 more
    • Beijing, Beijing, China
      Peking Univerisity Cancer Hospital
    Jan 10, 2022

    Hepatocellular Carcinoma With Major Portal Vein Thrombosis Trial (HAIC (Hepatic arterial infusion chemo), HLX10 (PD-1 antibody),

    Not yet recruiting
    • Hepatocellular Carcinoma With Major Portal Vein Thrombosis
    • HAIC (Hepatic arterial infusion chemotherapy)
    • +3 more
    • (no location specified)
    Jun 24, 2021

    Hepatocellular Carcinoma Trial in Guangzhou (Hepatic artery infusion chemo(HAIC), Durvalumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Hepatic artery infusion chemotherapy（HAIC）
    • Durvalumab
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    May 18, 2022

    Liver Cancer, Liver Transplant; Complications, Hepatocellular Carcinoma Trial in Shanghai (radiation, combination product, drug)

    Not yet recruiting
    • Liver Cancer
    • +4 more
    • intensity-modulated radiotherapy
    • +5 more
    • Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Apr 20, 2022

    Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)

    Recruiting
    • Radiotherapy
    • +3 more
    • Beijing, Beijing, China
      Bo Chen
    Mar 6, 2021

    Chronic Portal Vein Thrombosis in Children

    Not yet recruiting
    • Portal Vein Thrombosis
    • endoscopy
    • (no location specified)
    Nov 3, 2023

    Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Portal Vein Thrombosis
    • PBT and atezolizumab/bevacizumab
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Nov 15, 2022

    Hepatocellular Carcinoma, Portal Vein Occlusion, Tumor Thrombus Trial in Guangzhou (TACE combined with iodine-125 seeds

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • TACE combined with iodine-125 seeds implantation
    • TACE
    • Guangzhou, Guangdong, China
      The 2nd Affiliated Hospital of Guangzhou Medical University
    Mar 2, 2022

    Portal Vein Thrombosis in Neonate With Umbilical Catheter

    Not yet recruiting
    • Portal Vein Thrombosis
    • ultrasound and doppler
    • (no location specified)
    Nov 21, 2023

    Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)

    Not yet recruiting
    • Primary Hepatocellular Carcinoma
    • Portal Vein Thrombosis
    • Recombinant human adenovirus type 5 + TACE
    • (no location specified)
    May 14, 2023

    Unresectable Hepatocellular Carcinoma, Pembrolizumab, Lenvatinib Trial in Taipei City (Lenvatinib/Pembrolizumab plus SBRT

    Not yet recruiting
    • Unresectable Hepatocellular Carcinoma
    • +3 more
    • Lenvatinib/Pembrolizumab plus SBRT combinations
    • Taipei City, Taiawn, Taiwan
      National Taiwan University Hospital
    Jan 30, 2023

    Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding Trial in Chengdu (preemptive TIPS, standard second

    Not yet recruiting
    • Portal Hypertension
    • +3 more
    • preemptive TIPS
    • standard second prophylaxis
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Nov 3, 2023

    Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Trial in Shanghai (Tislelizumab, IMRT)

    Not yet recruiting
    • Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
    • Shanghai, China
      Zhongshan hospital, Fudan University
    Apr 19, 2021

    A Practical Nomogram Based on Systemic Inflammatory Markers for

    Completed
    • Systemic Inflammatory Markers
    • Portal Vein Thrombosis
    • clinical laboratory tests, and imaging characteristics
    • Qingdao, Shandong, China
      the Affiliated Hospital of Qingdao University
    Sep 13, 2022

    Hepatocellular Carcinoma Portal Vein Thrombosis After

    Not yet recruiting
    • Hepatocellular Carcinoma
    • trans arterial chemoembolization
    • (no location specified)
    Aug 4, 2022

    Deep Vein Thrombosis, Chronic Portal Vein Thrombosis Trial in Clichy (Xarelto)

    Completed
    • Deep Vein Thrombosis
    • Chronic Portal Vein Thrombosis
    • Clichy, France
      Hôpital Beaujon
    Jul 22, 2022

    Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • I-125 Seeds Brachytherapy in PVTT
    • +2 more
    • (no location specified)
    Aug 14, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (Cadonilimab, transjugular intrahepatic portosystemic shunt (TIPS))

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Cadonilimab
    • transjugular intrahepatic portosystemic shunt (TIPS)
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 30, 2023

    Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)

    Not yet recruiting
    • Stage IIIA Hepatocellular Carcinoma
    • Radiotherapy combined with TKI and Anti-PD-1 Antibody
    • (no location specified)
    Sep 24, 2023